Cel Sci CVM
NYSE CVM
$1.60 +0.05 (+3.23%)
As of: Oct 21, 2026 · 3:59 PM EDT

Cel Sci (CVM) EBIT Margin (2010 - 2023)

Updated

Cel Sci (CVM) reported EBIT Margin of -27366.26% for fiscal Q3 2017 (quarter ended Jun 30, 2017), down 22822.20 percentage points from -4544.06% a year earlier.

Analysis

Cel Sci (CVM) EBIT Margin (2010 - 2023) Analysis & Trends

Over the twelve months ended Jun 30, 2017, Cel Sci's EBIT Margin came in at -9481.25%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Cel Sci 2.88 Mn -22.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -5,140.26%
Sep 30, 2022 -2,360.86%
Mar 31, 2021 -3,272.67%
Jun 30, 2017 -27,366.26%
Jun 30, 2016 -4,544.06%
Jun 30, 2011 -6,260.41%
Jun 30, 2010 -10,984.01%
API Access

Cel Sci EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CVM&period=max&api_key=YOUR_API_KEY